Medical News

RSS

Patients with BPE may have Obstructive Sleep Apnea

Ben-Gurion University of the Negev researchers have shown that a significant number of patients with benign prostate enlargement may have Obstructive Sleep Apnea, which may be the reason for their night awakenings and urination.

16 Mar 2011

Montreal Heart Institute and Cerenis commence CER-001 Phase 2 study in acute coronary syndrome

The Montreal Heart Institute today announced the start of the Phase 2 CHI-SQUARE (Can HDL Infusions Significantly QUicken Atherosclerosis REgression?) study of CER-001 in patients with acute coronary syndrome (ACS), in collaboration with Cerenis Therapeutics, a biopharmaceutical company developing novel high-density lipoprotein (HDL) therapies to treat cardiovascular and metabolic diseases.

16 Mar 2011

Optimer receives U.S. patent for fidaxomicin to treat CDI

Optimer Pharmaceuticals, Inc. announced today that the United States Patent and Trademark Office has issued U.S. Patent 7,906,489 which covers methods of Clostridium difficile infection treatment with fidaxomicin.

16 Mar 2011

State roundup: Fla. seeks MLR waiver; hospitals struggle

Alabama's Robert Bentley is one of two current governors to have "doctor" on his résumé. In an interview with Stateline last week, Bentley elaborated on his health care agenda. His plan emphasizes individual health savings accounts, which he says will lower costs by letting patients decide how they want to spend their health care dollars. He wants to give state tax breaks to businesses that purchase insurance for their employees and state-based incentives to attract more insurance carriers.

16 Mar 2011

Plexxikon selects Clinipace to manage 4 clinical trials for RA treatment

Clinipace Worldwide, a global digital clinical research organization, announced today that Plexxikon Inc., a leader in the structure-guided discovery and development of novel small molecule pharmaceuticals to treat human disease, has selected Clinipace to manage all aspects of four clinical trials comprising a Phase 1 healthy volunteer study, a Phase 1b rheumatoid arthritis study, and two phase 2 oncology studies.

16 Mar 2011

New self-monitoring blood glucose sensor uses tear fluid as sample

People with diabetes could be helped by a new type of self-monitoring blood glucose sensor being developed by Arizona State University engineers and clinicians at Mayo Clinic in Arizona.

16 Mar 2011

TrustHCS enters partnership with RemitDATA to utilize TITAN in physician services practice

TrustHCS, an HIM, compliance and revenue cycle consultancy firm for healthcare providers, announces its partnership with RemitDATA to utilize TITAN in their physician services practice.

16 Mar 2011

SYSPRO, Avalara enter strategic partnership

SYSPRO, the leading provider of visionary, pragmatic ERP software, today announced a strategic partnership with Avalara, a leading provider of fully automated, up-to-date sales and use tax compliance solutions. SYSPRO will now offer AvaTax for SYSPRO, a solution that leverages off the open SYSPRO technology architecture to deliver a totally integrated service that speeds up and simplifies the exacting taxation requirements of SMB manufacturers and distributors.

16 Mar 2011

Insight into Lyme disease

Researchers recently developed novel diagnostic tools able to distinguish between the various strains of bacteria responsible for causing Lyme disease. For more than a decade, only one strain of B. burgdorferi had been sequenced, and although that helped research efforts, it was not sufficient to understand the relationship between geographic variations in strains and disease characteristics.

16 Mar 2011

Anti-cancer drug loaded microcarriers successfully guided to targeted area in the liver

Soon, drug delivery that precisely targets cancerous cells without exposing the healthy surrounding tissue to the medication's toxic effects will no longer be an oncologist's dream but a medical reality, thanks to the work of Professor Sylvain Martel, Director of the Nanorobotics Laboratory at Polytechnique Montr-al.

16 Mar 2011

Manchester research offers hope for congenital hyperinsulinism treatment

University of Manchester scientists have led an international team to discover new treatments for a rare and potentially lethal childhood disease that is the clinical opposite of diabetes mellitus.

16 Mar 2011

Classifying gambling subtypes does not predict treatment outcomes

Approximately two million adults in the United States meet criteria for pathological gambling, and another four to six million are considered problem gamblers, according to the National Council on Problem Gambling. A study by researchers at Wayne State University reveals that gambling addiction treatment is not one-size-fits-all, but it is difficult to predict which style of treatment is best for the various forms of gambling addiction.

16 Mar 2011

Researchers identify genetic cause of magnesium deficiency

Researchers and scientists of the Charité - Universitätsmedizin Berlin, in cooperation with the Max Delbrück Center for Molecular Medicine, and colleagues from the Netherlands, Belgium, Switzerland and the Czech Republic have succeeded in identifying a genetic cause of magnesium deficiency.

16 Mar 2011

Global settlement agreement reached in Tuschl patents litigation

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced the signing of a global settlement agreement among Alnylam, Max Planck Society ("Max Planck"), the Whitehead Institute for Biomedical Research ("Whitehead") and the University of Massachusetts ("UMass") resolving their ongoing litigation regarding the Tuschl patents.

16 Mar 2011

BRAF gene defect leads to pilocytic astrocytoma in children

Pilocytic astrocytoma, the most common brain tumor in children, is usually slow-growing and benign. However, surgeons often cannot completely remove the diffusely growing tumor.

16 Mar 2011

ASL releases new eye tracking software solution

Applied Science Laboratories, the true authority on eye tracking, has released its highly anticipated analysis software, ASL Results for the Mobile Eye solution. This revolutionary program makes measuring consumer response, human behavior and physiology faster and easier than ever, proving to be a game changer for the eye tracking industry.

16 Mar 2011

Mile Square earns excellence in heart care

Mile Square Health Center at 2045 W. Washington Blvd. was named an Illinois "Your Healthcare Plus" top performer for excellence in caring for patients with heart failure.

16 Mar 2011

Viewpoints: Texas' painful budget cuts; Congress 'should' attack deficit, Medicare costs

The real problem is that liberals and conservatives alike have over the years gauged an elected official's support for the goals of a program by the money he or she has been willing to spend on it. Thus, liberals measure one's support for education, welfare and health programs by how much more one votes to fund them each year.

16 Mar 2011

Researchers discover molecular switch for insulin secretion

Johns Hopkins researchers believe they have uncovered the molecular switch for the secretion of insulin — the hormone that regulates blood sugar — providing for the first time an explanation of this process.

16 Mar 2011

A Medicare mistake: Paying for Viagra

The Department of Health and Human Services Office of the Inspector General concluded that the program paid more than $3 million in 2007 and 2008 for this drug, even though it is against the law for Medicare to pay for Viagra prescriptions.

16 Mar 2011